PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
Status:
Completed
Trial end date:
2017-01-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether apremilast is safe and effective in the
treatment of patients with psoriatic arthritis.
Apremilast is proposed to improve signs and symptoms of psoriatic arthritis (tender and
swollen joints, pain, physical function) in treated patients.